Ambarish Pandey

Univ Texas Southwestern Med Ctr

Author of 7 Presentation(s)

32. Prevention: Clinical 1006-17

1006-17 - TRENDS IN UTILIZATION OF GENERIC AND BRAND-NAME LDL-LOWERING PRESCRIPTION DRUGS AMONG MEDICARE PART D BENEFICIARIES BETWEEN 2013 AND 2017

Session
1006 - How Can a "Learning Health Care System" Inform Cardiovascular Prevention Community?
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
1006-17
Presentation Rating
 5
13. Heart Failure and Cardiomyopathies: Clinical 1205-80

1205-80 - VISIT-TO-VISIT VARIABILITY IN RENAL FUNCTION AND RISK OF MORTALITY AMONG PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

Session
1205 - Heart Failure and Cardiomyopathies: Clinical 3
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1205-80
Presentation Rating
 5
13. Heart Failure and Cardiomyopathies: Clinical 1205-133
32. Prevention: Clinical 1209-122

1209-122 - STALLED NATIONAL PROGRESS IN HEART FAILURE HOSPITALIZATIONS AMONG PATIENTS WITH DIABETES MELLITUS

Session
1209 - Prevention: Clinical 3
Pathway
32. Prevention: Clinical
Presentation Number
1209-122
Presentation Rating
 Not Rated
13. Heart Failure and Cardiomyopathies: Clinical 1260-098

1260-098 - IMPACT OF BODY SIZE ON SURGICAL CORONARY REVASCULARIZATION FOR ISCHEMIC HEART FAILURE: INSIGHTS FROM STICHES

Session
1260 - Heart Failure and Cardiomyopathies: Clinical 4
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1260-098
Presentation Rating
 Not Rated
13. Heart Failure and Cardiomyopathies: Clinical 1260-114

Author of 1 Presentation

32. Prevention: Clinical 1006-17

1006-17 - TRENDS IN UTILIZATION OF GENERIC AND BRAND-NAME LDL-LOWERING PRESCRIPTION DRUGS AMONG MEDICARE PART D BENEFICIARIES BETWEEN 2013 AND 2017

Session
1006 - How Can a "Learning Health Care System" Inform Cardiovascular Prevention Community?
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
1006-17
Presentation Rating
 5

Author of 6 Presentation(s)

13. Heart Failure and Cardiomyopathies: Clinical 1205-80

1205-80 - VISIT-TO-VISIT VARIABILITY IN RENAL FUNCTION AND RISK OF MORTALITY AMONG PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

Session
1205 - Heart Failure and Cardiomyopathies: Clinical 3
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1205-80
Presentation Rating
 5
13. Heart Failure and Cardiomyopathies: Clinical 1205-133
32. Prevention: Clinical 1209-122

1209-122 - STALLED NATIONAL PROGRESS IN HEART FAILURE HOSPITALIZATIONS AMONG PATIENTS WITH DIABETES MELLITUS

Session
1209 - Prevention: Clinical 3
Pathway
32. Prevention: Clinical
Presentation Number
1209-122
Presentation Rating
 Not Rated
13. Heart Failure and Cardiomyopathies: Clinical 1260-098

1260-098 - IMPACT OF BODY SIZE ON SURGICAL CORONARY REVASCULARIZATION FOR ISCHEMIC HEART FAILURE: INSIGHTS FROM STICHES

Session
1260 - Heart Failure and Cardiomyopathies: Clinical 4
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1260-098
Presentation Rating
 Not Rated
13. Heart Failure and Cardiomyopathies: Clinical 1260-114